Skip to content
Abierto

Award notice

Rivastigmine 24HR Patches

SPE2D221R0113

Defense Logistics Agency, DLA Troop Support. Pharmaceutical Preparation Manufacturing.

Awarded

Mylan Pharmaceuticals Inc.

$10,967,220.00 on the award notice, September 14, 2022, contract SPE2D222D0147

Description

As published on SAM.gov.

Modification SPE2D222D0147 P00005 to Invoke Option Year 2 for the period of September 14, 2024 through September 13, 2025. Modification SPE2D222D0147 P00004 to Invoke THIS CONTRACT IS MODIFIED TO INCLUDE 52.204-30 Federal Acquisition Supply Chain Security Act Orders. Modification SPE2D222D0147 P00003 to Invoke Option Year 1 for the period of September 14, 2023 through September 13, 2024. Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract.

Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract. Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
NDN1MYB8DKK5
CAGE
3KJG9
Vendor location
Morgantown, WV
Contract
SPE2D222D0147
Obligated
$0.00, potential $10,967,220
Actions
4 between May 21, 2024 and August 21, 2025
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
4610094214!manufacture/Distributor Br-Philadelphia
Match
award number SPE2D222D0147 equals the contract number; same awarding office SPE2D2 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 14, 2024

    Award notice

    Awarded to Mylan Pharmaceuticals Inc. Morgantown for $10,967,220. SAM.gov, notice a698f0c810ca42efb26f9b0af94e960e

Points of contact